Audit Compensation Nominating and Corporate Governance
Larry Ellberger Chairman of the Board Financial Expert Member of Audit Committee   Member of Nominating and Corporate Governance Committee
Keith L. Brownlie Financial Expert Committee Chair for Audit Committee    
Herbert J. Conrad   Member of Compensation Committee Member of Nominating and Corporate Governance Committee
James J. Marino,, J.D.   Committee Chair for Compensation Committee  
Harry H. Penner, Jr., J.D., L.L.M. Member of Audit Committee Member of Compensation Committee  
Karen L. Shoos, J.D.     Committee Chair for Nominating and Corporate Governance Committee
Consultant, AABB International Technical Assistance, Division of Global Services

Ms. Shoos has been a director of Celldex since the merger between Celldex and AVANT Immunotherapeutics in March 2008 and had been a director of AVANT since May 2001. From May 2013 to September 2016, Ms. Shoos was Principal Investigator, AABB International Technical Assistance, a professional standards setting and accrediting organization in the fields of blood and cellular therapies, and from 1994 to 2013, she was the Chief Executive Officer. From 1984 to 1994, she held senior positions at the American Red Cross, including Acting Senior Vice President, Biomedical Services, as well as General Counsel and Secretary. Prior to the American Red Cross, Ms. Shoos was a lawyer in private practice. She received her B.A. from Yale University and J.D. from Case Western Reserve University.


Holdings: 41,833 shares     View Transactions
Chair of the Board = Chair of the Board Committee Chair = Chair Committee Member = Member Financial Expert = Financial Expert
Chair of the Board = Chair of the Board
Committee Chair = Chair
Committee Member = Member
Financial Expert = Financial Expert

Stock transaction information provided by EDGAR Online. Celldex Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.